Inspire Medical Systems expects $90M-$100M tax benefit from valuation allowance release

Inspire Medical Systems, Inc.

Company disclosed expectation to release a significant portion of valuation allowance on U.S. deferred tax assets.
Estimated income tax benefit of $90 million to $100 million for fiscal year 2025.
Diluted earnings per share expected to increase by approximately $3.00 to $3.30.
Disclosure made on November 6, 2025, and filed on November 17, 2025.
The benefit will be recorded in the fourth quarter of fiscal 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.